OTC Naproxen Labeling: US FDA Advisory Panel Finds Imprecise Direction In PRECISION

Safety study of celecoxib vs. ibuprofen and naproxen spurs advisory committees to recommend adding aspirin-interaction warning on OTC naproxen labels...

More From BioPortfolio on "OTC Naproxen Labeling: US FDA Advisory Panel Finds Imprecise Direction In PRECISION"